2.5.2024
6
May
2024
7
8
Find more news and events
Suomeksi
In English
In vitro and in vivo methodologies were employed to investigate ocular drug metabolism across species and ocular tissues.
Tetsuya Terasaki has opened a new research field of pharmacoproteomics, which is expected to play an important role in the progress of the pharmaceutical and biomedical sciences in the next decade.
Boosting virtual screening with machine learning allowed for a 10-fold time reduction in the processing of 1.56 billion drug-like molecules.
The Finnish Research Impact Foundation (FRIF) has granted 2.1 million euros of funding to joint research projects between universities and corporate partners.
The doctoral research covers preclinical studies performed to obtain the comprehensive pharmacokinetic parameters of two important ocular drugs: brinzolamide and dexamethasone.
Beta-2 agonists are bronchodilators commonly used in the treatment of asthma and chronic obstructive pulmonary disease (COPD).
The Academy of Finland’s Research Council for Natural Sciences and Engineering has granted 3.5 million euros of funding to new Academy Projects at the University of Eastern Finland.
The project will examine the use of lipid nanoparticles in transporting mRNA into ocular tissues.
The Academy of Finland’s Research Council for Biosciences, Health and the Environment granted more than 5.2 million euros of funding to Academy Projects at the University of Eastern Finland.
The University of Eastern Finland will showcase its expertise in collaboration with Kuopio Health at Radical Health Festival Helsinki 2023, a new pan-European conference bringing together key players in digital health.